Follow-up care for men with prostate cancer and the role of primary care: A systematic review of international guidelines

British Journal of Cancer

Volumn 100, Issue 12, 2009, Pages 1852-1860

  McIntosh, H M ^a   Neal, R D ^b   Rose, P ^c   Watson, E ^d   Wilkinson, C ^b   Weller, D ^a   Campbell, C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Follow up; Guidelines; Prostate cancer; Systematic review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BRACHYTHERAPY; CLINICAL OBSERVATION; DIGITAL RECTAL EXAMINATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; MALE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RELIABILITY; REVIEW; SYSTEMATIC REVIEW; THEORETICAL MODEL;

AFTERCARE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL AGENCIES; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS;

EID: 67349158620     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605080     Document Type: Review

References (49)

1. *Alberta Cancer Board (2007) Clinical Practice Guideline Prostate Cancer. http://www.cancerboard.ab.ca/NR/rdonlyres/D9B8A40C-A089-45CE-8FAC- D7BBE6448FFA/0/GU-004-ProstateCancer.pdf [accessed 14 Jan 2009]
2. *American College of Radiology (2005) Practice guideline for transperineal permanent brachytherapy of prostate cancer. http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/guidelines/ro/brachy-prostate-cancer. aspx [accessed 14 Jan 2009]
3. *American Urological Association (2000) Prostate-specific antigen (PSA) best practice policy. Oncology 14: 267-286
4. *Ash D, Flynn A, Batterman J, de Reijke T, Lavagnini P, Blank L (2000) STRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57: 315-321
5. Barr VJ, Robinson S, Marin-Link B, Underhill L, Dotts A, Ravensdale D, Salivaras S (2003) The expanded chronic care model: an integration of concepts and strategies from population health promotion and the Chronic Care Model. Hosp Q 7: 73-82
6. *British Colombia Cancer Agency (2001) Cancer Management Guidelines: rostate. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/ Genitourinary/Prostate/Management/Followup/default.htm [accessed 14 Jan 2009]
7. Burgers JS (2006) Guideline quality and guideline content: are they related? Clin Chem 52: 3-4
8. Burgers JS, Bailey JV, Klazinga NS, Van der Bij AK, Grol R, Feder G, for the AGREE Collaboration (2002) Inside Guidelines. Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 25: 1933-1939
9. Campbell NC, MacLeod U, Weller D (2002) Primary care oncology: ssential if high quality cancer care is to be achieved. Fam Pract 19: 577-578
10. *Cancer Care Nova Scotia (2006) Guidelines for the Management of rostate Cancer. http://www.cancercare.ns.ca/site-cc/media/cancercare/ ProstateGuidelinesFullVersion2006(1).pdf [accessed 24 Apr 2009]
11. Dahm P, Kunz R, Schünemann H (2007) Evidence-based clinical practice guidelines for prostate cancer: the need for a unified approach. Curr Opin Urol 17: 200-207
12. Department of Health (2005) Tackling Cancer: Improving the Patient Journey. The Stationery Office: London
13. Department of Health (2007) Cancer reform strategy. http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ dh-081006 [accessed 31 July 2008]
14. *Dutch Institute for Healthcare Improvement (CBO) (2007) Prostate cancer Guidelines: diagnosis and treatment [Dutch]. http://www.cbo.nl/product/ richtlijnen/folder20021023121843/rl-prostaat-carc-2007.pdf [accessed 14 Jan 2009]
15. Eisinger F, Geller G, Burke W, Holtzman NA (1999) Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 353: 919-920
16. *European Association of Urology (2007) Guidelines on prostate cancer. http://www.uroweb.org/fileadmin/tx-eauguidelines/Prostate%20Cancer. pdf [accessed 14 Jan 2009]
17. *European Society for Medical Oncology (2007) Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 18(Suppl 2): ii36-ii37
18. Faithfull S, Corner J, Meyer L, Huddart R, Dearnaley D (2001) Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy. Br J Cancer 85: 1853-1864
19. Ferlay J, Autier M, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592
20. Fervers B, Burgers JS, Haugh MC, Brouwers M, Browman GCF, Philip T (2005) Predictors of high quality clinical practice guidelines: examples in oncology. Int J Qual Health Care 17: 123-132
21. *Finnish Medical Society Duodecim Current Care Guidelines (FCCG) (2007) Prostate cancer [Finnish]. http://www.kaypahoito.fi/kh/kaypahoi-to? suositus = hoi11060 [accessed 14 Jan 2009]
22. Foy R, MacLennan G, Grimshaw J, Penney G, Campbell M, Grol R (2002) Attributes of clinical guidelines recommendations that influence change in practice following audit and feedback. J Clin Epidemiol 55: 717-722
23. *French Federation of Comprehensive Cancer Centres (2006) Clinical practice recommendations, Standards, Options and Recommendations for the management of nonmetastatic prostate cancer [French]. http:// www.sor-cancer.fr/index.php?tg=fileman&idx = get&inl=1&id = 2&gr = Y&path=organes+genitaux+masculins%2Fcancer+de+la+prostate% 2Fcancer+de+la+prostate&file = Bulletin+de+synth%E8se+2006.pdf [accessed 14 Jan 2009]
24. Fretheim A, Schünemann HJ, Oxman AD (2006) Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst 4: 15
25. Grol R, Cluzeau FA, Burgers JS (2003) Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer 89: S4-S8
26. Grol R, Dalhuijsen J, Thomas S, in't Veld C, Rutten G, Mokkink H (1998) Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 317: 858-861
27. Grunfeld E (2006) Looking beyond survival: how are we looking at survivorship? J Clin Oncol 24: 5166-5169
28. Hasse A, Follmann M, Skipka G, Kirchner H (2007) Developing search strategies for clinical practice guidelines in SUMSearch and Google Scholar and assessing their retrieval performance. BMC Med Res Methodol 7: 28
29. Helgesen F, Andersson SO, Gustafsson O, Varenhorst E, Goben B, Carnock S, Sehlstedt L, Carlsson P, Holmberg L, Johansson JE (2000) Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: a randomized study. Scand J Urol Nephrol 34: 55-61
30. Martin RM, Gunnell D, Hamdy F, Neal D, Lane A, Donovan J (2006) Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era. J Urol 176: 439-449
31. Meyer J-P, Sullivan ME, Bell RCRW (2006) Urological cancer guidelines: are there any differences? BJU Int 98: 940-941
32. Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CFB, Askham J (1998) Consensus development methods, and their use in clinical guideline development. Hzealth Technol Assess 2(3): 1-88
33. Neal RD (2008) The role of the GP in prostate cancer care. Trends Urol Gynaecol Sex Health 13: 27-30
34. NHS (2000) The NHS Cancer Plan. http://www.dh.gov.uk/en/Publication- sandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4009609 [accessed 11 November 2008]
35. Nord C, Ganz PA, Aziz N, Fosså SD (2007) Follow-up of long-term cancer survivors in the Nordic countries. Acta Oncol 46: 433-440
36. Oeffinger KC, McCabe M (2006) Models for delivering survivorship care. J Clin Oncol 24: 5117-5124
37. *Ontario Ministry of Health and Long-Term Care (2002) Ontario prostate specific antigen (PSA) clinical guidelines. http://www.health.gov.on. ca/ english/providers/pub/cancer/psa/psa-guide/psa-mdref.pdf [accessed 14 Jan 2009]
38. Pascoe SW, Neal RD, Allgar VL, Selby PJ, Wright EP (2004) Psychological care for cancer patients in primary care? Recognition of opportunities for cancer care. Fam Pract 21: 437-442
39. Philip T, Fervers B, Haugh M, Otter R, Browman G (2003) European cooperation for clinical practice guidelines in cancer. Br J Cancer 89: S1-S3
40. Raine R, Sanderson C, Black N (2005) Developing clinical guidelines: a challenge to current methods. BMJ 331: 631-633
41. *Richaud P, Moreau J-L, Beuzeboc P, Rébillard X, Villers A, Peyromaure M, Cornud F, Soulié M, Davin J-L (2005) Follow-up of prostate cancer [French]. Prog Urol 15: 586-592
42. Shekelle PG, Woolf SH, Eccles M, Grimshaw J (1999) Developing guidelines. BMJ 318: 593-596
43. *Swedish National Board of Health and Welfare (SBHW) (2007) National guideline for prostate cancer management [Swedish]. http://www.social-styrelsen.se/NR/rdonlyres/C149EC33-888D-4E30-AE40- 84DBA21D152F/ 7340/20071029.pdf [accessed 14 Jan 2009]
44. *The National Comprehensive Cancer Network (2007) NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. http://www.nccn.org/ professionals/physician-gls/PDF/prostate.pdf [accessed 14 Jan 2009]
45. *The National Institute for Health and Clinical Excellence (NICE) (2002) Guidance on Cancer Services. Improving outcomes in urological cancers: The Manual. http://www.nice.org.uk/nicemedia/pdf/Urological-Manual.pdf [accessed 14 Jan 2009]
46. *The National Institute for Health and Clinical Excellence (NICE (2008) Prostate cancer: diagnosis and treatment. http://www.nice.org.uk/nice- media/pdf/CG58FullGuideline.pdf [accessed 14 Jan 2009]
47. *The Royal College of Radiologists' Clinical Oncology Information Network (1999) Guidelines on the management of prostate cancer. BJU Int 84: 987-1014
48. Vlayen J, Aertgeerts B, Hannes K, Serneus W, Ramaekers D (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17: 235-242
49. Warren KS, McFarlane JP (2007) Is routine digital rectal examination required for the followup of prostate cancer? J Urol 178: 115-119